Zegalogue .6 mg/.6mL

Zegalogue 0.6 mg/0.6mL is a glucagon injection used for severe hypoglycemia. This solution is administered subcutaneously and is manufactured by Novo Nordisk in the USA.

Zegalogue is primarily used to treat severe hypoglycemia, a condition characterized by dangerously low blood sugar levels. It works by raising blood glucose levels quickly. This medication is typically administered when a person is unable to consume food or drink orally. Zegalogue may also be used in other situations where rapid glucose elevation is necessary, as determined by a healthcare provider.

Common effects of Zegalogue may include temporary increases in heart rate and blood pressure. Some individuals might experience nausea or vomiting. These effects are generally short-lived and resolve as the medication's action subsides. Always consult a healthcare provider for personalized advice.

Zegalogue should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for use and to be aware of any potential allergic reactions. Always keep this medication out of reach of children and store it as directed.

Zegalogue may interact with certain medications, including those that affect blood sugar levels or heart function. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also influence the effects of Zegalogue.